Biggar Stephen R 4
4 · SYNAGEVA BIOPHARMA CORP · Filed Dec 21, 2011
Insider Transaction Report
Form 4
Biggar Stephen R
Director
Transactions
- Award
Stock Option (Right to Buy)
2011-12-20−15,000→ 15,000 totalExercise: $23.00Exp: 2021-12-19→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]1/36 of the shares subject to this option vest and become exercisable on December 2, 2011 and monthly thereafter.